touchPODCAST
Avsnitt

Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management

Dela

touchCASES for touchONCOLOGY

Join two international experts as they walk through three real-world patient stories, showing how molecular testing shapes treatment choices in advanced endometrial cancer and how immune-related side effects can be recognized and managed in everyday practice.     

The experts:

  • Dr Nicoletta Colombo, European Institute of Oncology, Milan, Italy
  • Dr Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

This activity is supported by an independent educational grant from Merck Sharp & Dohme LLC.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information, visit our website: www.touchONCOLOGY.com

Podden och tillhörande omslagsbild på den här sidan tillhör touchpodcast. Innehållet i podden är skapat av touchpodcast och inte av, eller tillsammans med, Poddtoppen.